康泰生物：关于控股股东的一致行动人减持计划预披露的公告

Core Points - The company announced that its controlling shareholder, Du Xinglian, plans to reduce her shareholding by up to 2,724,048 shares, which represents 0.24% of the total share capital [1] - The reduction will take place within three months after the announcement, excluding periods when reductions are legally prohibited [1] - The implementation of this reduction plan will not affect the company's governance structure or ongoing operations, nor will it lead to a change in control of the company [1]